SAVE THE DATE
November 15-16, 2019
Diabetes and Obesity in Renal Disease in 2019, an update
A new educational event organised by Diabesity, an official ERA-EDTA Working Group
Alcorcón, Madrid (Spain)
The fast growing prevalence of obesity, metabolic syndrome and type 2 diabetes is an important challenge in nephrology. These entities are deeply interrelated. In fact, obesity and metabolic syndrome frequently precede diabetes.
Obesity itself can cause specific renal disease such as obesity-related glomerulopathy or increase the risk for progression of kidney diseases irrespective of the underlying cause. The pathways involved in renal disease associated with obesity, metabolic syndrome and diabetes are not completely known. Renal lipotoxicity and inflammation are major areas of research and could be involved in renal damage in these metabolic complications. Evidence of complementary small and large animal models may help to understand renal disease in these conditions. Finally, recent evidence in cardiovascular and renal protection of specific diets and new medications seem to offer promising alternatives to patients with type 2 diabetes and renal disease.
CALL FOR ABSTRACTS
Diabesity Working Group welcomes the submission of abstracts for original works in the field of diabetes, obesity and renal diseases. The Scientific Committee of the CME will make the selection of abstracts for Poster Presentation or Oral Communication.
Please send your abstract as a PDF document to the following e-mail address:
The abstract submission deadline will be October, 15, 2019.